Show simple item record

dc.creatorPapapietro V,Karin
dc.creatorDíaz G,Emma
dc.creatorCsendes J,Attila
dc.creatorDíaz J,Juan Carlos
dc.creatorBraghetto M,Italo
dc.creatorBurdiles P,Patricio
dc.creatorMaluenda G,Fernando
dc.creatorRojas C,Jorge
dc.date2005-05-01
dc.date.accessioned2020-02-17T15:36:05Z
dc.date.available2020-02-17T15:36:05Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000500001
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/132236
dc.descriptionBackground: Type 2 diabetes, hypertension and serum lipid abnormalities are common among obese people and they should improve with weight reduction. Aim: To study the outcome of these abnormalities after bariatric surgery in morbid obesity patients. Material and methods: Two hundred thirty two morbid obese patients subjected to gastric bypass, were evaluated in the preoperative period and every three months after surgery, during a minimum of 12 months. Clinical evolution, blood glucose, serum insulin, insulin resistance measured with the homeostasis model assessment (HOMA) and serum lipid levels were analyzed. Results: In the preoperative period, 17% had type 2 diabetes, 49% had abnormal serum lipid levels and 25% had high blood pressure. Sixty six percent had at least one of these abnormalities and 20% had more than one. During follow up, body mass index decreased from 44 to 29.3 kg/m2. Total and HDL cholesterol, blood glucose and insulin resistance significantly decreased from the third month after surgery. Diabetes disappeared in 97% of diabetic subjects, blood pressure normalized in 53% of subjects with hypertension and serum lipid levels returned to normal in 88% of subjects with dyslipidemia. Conclusions: Gastric bypass in morbid obese patients achieves a significant and important weight reduction that results in significant reductions in the frequency of diabetes, dyslipidemia and hypertension among operated obese subjects
dc.formattext/html
dc.languagees
dc.publisherSociedad Médica de Santiago
dc.relation10.4067/S0034-98872005000500001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista médica de Chile v.133 n.5 2005
dc.subjectDiabetes Mellitus, type 2
dc.subjectGastric bypass
dc.subjectObesity, morbid
dc.titleEvolución de comorbilidades metabólicas asociadas a obesidad después de cirugía bariátrica


This item appears in the following Collection(s)

Show simple item record